CN Stock MarketDetailed Quotes

603896 Zhejiang Shouxiangu Pharmaceutical

Watchlist
  • 18.99
  • -0.61-3.11%
Market Closed Sep 13 15:00 CST
3.76BMarket Cap14.20P/E (TTM)

Zhejiang Shouxiangu Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-35.42%1.1B
-0.16%1.62B
-1.36%1.5B
45.60%1.42B
112.04%1.7B
130.18%1.62B
124.89%1.52B
70.23%974.62M
14.06%800.04M
3.40%705.67M
Transactional financial assets
--270M
----
----
----
----
-73.33%30M
-76.92%30M
-82.35%30M
-45.45%30M
81.45%112.5M
Notes receivable and accounts receivable
12.60%123.24M
29.50%164.35M
-18.68%111.93M
90.55%119.41M
90.60%109.44M
43.23%126.92M
62.86%137.65M
14.08%62.67M
34.98%57.42M
32.56%88.61M
-Notes receivable
4.33%25.04M
-50.50%18.94M
-13.10%20.84M
--14.28M
--24M
--38.27M
--23.99M
----
----
----
-Accounts receivable
14.93%98.2M
64.03%145.41M
-19.86%91.09M
67.76%105.13M
48.81%85.44M
0.04%88.65M
34.48%113.66M
14.08%62.67M
34.98%57.42M
32.56%88.61M
Other receivables (including interest and dividends)
-29.94%4.07M
28.83%4.6M
29.63%3.25M
9.87%3.97M
64.30%5.81M
0.97%3.57M
-14.07%2.51M
-1.99%3.61M
5.79%3.54M
24.01%3.54M
-Other receivable
-29.94%4.07M
----
29.63%3.25M
----
64.30%5.81M
----
-14.07%2.51M
----
5.79%3.54M
----
Advance payment
-27.81%10.4M
-20.56%12.07M
47.91%20.66M
-12.45%12.94M
16.91%14.4M
40.25%15.19M
32.11%13.97M
26.09%14.78M
23.19%12.32M
-23.18%10.83M
Inventories
11.73%207.03M
0.93%166.39M
6.82%157.83M
3.61%179.5M
8.29%185.29M
26.44%164.85M
49.16%147.76M
21.42%173.25M
15.57%171.11M
4.02%130.38M
Receivable financing
-9.78%329K
346.51%1.38M
3,396.58%1.13M
-95.13%403.46K
-95.89%364.68K
-99.00%309.08K
-99.90%32.37K
-27.08%8.29M
-35.12%8.88M
40.90%30.99M
Other current assets
318.80%10.75M
220.27%12.04M
49.88%8.08M
-6.34%7.81M
-73.57%2.57M
22.89%3.76M
-28.28%5.39M
203.11%8.33M
399.59%9.72M
61.09%3.06M
Adjustment items of current assets
----
--0.01
----
----
----
----
----
----
----
----
Total current assets
-14.55%1.72B
0.69%1.98B
-2.96%1.81B
36.65%1.74B
84.28%2.01B
81.37%1.97B
78.13%1.86B
31.54%1.28B
11.99%1.09B
11.06%1.09B
Non Current assets
Other equity investment
19.50%75.14M
14.98%72.56M
6.39%59.98M
14.67%62.71M
-1.49%62.88M
-0.35%63.11M
-4.26%56.37M
-10.95%54.69M
-1.81%63.83M
-11.63%63.33M
Other non-current financial assets
----
----
----
--0
----
-45.65%1.5M
-45.65%1.5M
-90.06%1.5M
-90.06%1.5M
-81.71%2.76M
Investment real estate
-5.03%218.49M
-5.26%220.8M
15.12%223.76M
15.37%227.08M
15.44%230.06M
15.51%233.05M
-4.81%194.38M
-4.76%196.84M
-4.06%199.3M
-4.00%201.75M
Long-term equity investment
4.76%5.71M
-1.54%5.9M
-3.20%5.74M
-6.93%5.51M
-8.78%5.45M
-4.59%5.99M
23.03%5.93M
12.04%5.92M
11.54%5.97M
12.60%6.28M
Fixed assets
-7.77%320.64M
----
-11.13%335.01M
----
0.21%347.67M
----
5.45%376.95M
----
-3.73%346.94M
----
Constru in process
176.79%400.07M
----
65.19%280.21M
----
-7.40%144.54M
----
47.07%169.63M
----
1,791.18%156.09M
----
Productive biological assets
-11.95%29.5M
-1.98%34.84M
4.01%31.38M
12.20%30.53M
24.27%33.51M
37.86%35.55M
34.64%30.17M
73.70%27.21M
32.01%26.96M
8.98%25.79M
Intangible assets
-5.86%89.26M
-8.35%87.76M
297.88%310.98M
296.38%313.77M
17.98%94.81M
17.20%95.76M
-5.81%78.16M
-5.60%79.16M
4.33%80.36M
4.63%81.7M
Long deferred expense
44.75%70.19M
49.85%75.31M
50.15%79.78M
3.14%45.87M
32.72%48.49M
37.27%50.26M
33.07%53.13M
29.29%44.47M
1.36%36.54M
-2.24%36.61M
Deferred tax assets
----
----
----
----
----
----
----
-0.32%311.98K
-81.06%278.3K
-67.75%366.26K
Usufruct assets
6.91%39.77M
42.91%34.46M
46.49%35.72M
74.10%35.27M
95.15%37.2M
20.11%24.11M
17.77%24.38M
16.48%20.26M
2.13%19.06M
7.94%20.08M
Other non current assets
1,691.46%136.64M
804.28%60.65M
38.97%4.95M
-13.90%12.08M
-55.47%7.63M
-67.46%6.71M
-51.18%3.56M
-56.72%14.03M
-2.50%17.13M
43.89%20.61M
Total non current assets
36.87%1.39B
22.34%1.24B
37.55%1.37B
28.71%1.23B
6.11%1.01B
7.21%1.02B
8.40%994.18M
12.25%958.86M
14.52%953.96M
14.12%947.62M
Total assets
2.65%3.11B
8.06%3.23B
11.14%3.17B
33.24%2.98B
47.85%3.03B
46.81%2.98B
45.54%2.86B
22.51%2.23B
13.15%2.05B
12.46%2.03B
Liabilities
Current liabilities
Short term loan
-33.02%246.18M
15.18%394.23M
36.34%372.16M
74.74%332M
--367.52M
--342.27M
--272.97M
--190M
----
----
Notes payable and accounts payable
2.78%167.84M
-33.47%97.08M
1.29%145.82M
-24.72%116.79M
-16.08%163.3M
-11.61%145.92M
2.24%143.96M
14.55%155.14M
19.81%194.6M
28.77%165.1M
-Accounts payable
2.78%167.84M
-33.47%97.08M
1.29%145.82M
-24.72%116.79M
-16.08%163.3M
-11.61%145.92M
2.24%143.96M
14.55%155.14M
19.81%194.6M
28.77%165.1M
Contract liabilities
11.47%9.7M
20.18%10.55M
8.37%8.98M
26.66%10.06M
-3.39%8.7M
-16.19%8.78M
-2.85%8.28M
-28.42%7.94M
4.09%9.01M
5.52%10.47M
Advance receipts
27.93%1.45M
-17.11%1.35M
50.17%1.13M
-66.79%780.61K
-32.24%1.13M
132.81%1.63M
-30.40%751.68K
--2.35M
--1.67M
--701.27K
Salaries payable
-8.70%22.42M
-4.05%18.42M
-9.32%29.09M
3.83%29.81M
5.02%24.56M
7.03%19.2M
13.50%32.08M
21.10%28.71M
23.26%23.38M
16.11%17.94M
Taxs payable
-2.50%3.4M
48.05%6.98M
16.01%9.53M
7.50%8.67M
-60.63%3.49M
37.04%4.71M
100.04%8.22M
-25.21%8.06M
155.51%8.86M
-40.21%3.44M
Other payable (including interest and dividends)
-92.55%2.84M
184.51%7.32M
-6.35%5.36M
-56.13%2.76M
231.80%38.1M
-55.30%2.57M
-42.18%5.73M
0.77%6.29M
40.59%11.48M
15.89%5.76M
-Dividend payable
----
----
----
----
--35.07M
----
----
----
----
----
-Other payable
-6.45%2.84M
----
-6.35%5.36M
----
-73.59%3.03M
----
-42.18%5.73M
----
65.35%11.48M
----
Non current liabilities due within one year
5.94%10.68M
44.81%7.92M
147.88%12.08M
66.50%9.81M
91.89%10.09M
7.99%5.47M
-13.48%4.87M
59.52%5.89M
39.32%5.26M
6.56%5.06M
Other current liabilities
9.57%1.07M
16.18%1.15M
9.90%1M
29.13%1.12M
-3.91%974.38K
-14.92%986.58K
-4.96%910K
-19.67%865.64K
-96.35%1.01M
-95.92%1.16M
Total current liabilities
-24.65%465.58M
2.53%545.01M
22.48%585.15M
26.29%511.8M
142.03%617.86M
153.56%531.55M
139.75%477.77M
111.03%405.26M
9.46%255.28M
6.17%209.63M
Current liabilities
Bonds payable
6.46%352.01M
-17.54%346.05M
-17.55%340.19M
269.06%336.33M
269.41%330.64M
372.79%419.67M
371.00%412.59M
0.83%91.13M
-15.06%89.51M
-42.86%88.77M
Deferred tax liabilities
45.53%6.02M
30.57%5.4M
24.10%3.78M
16.66%4.01M
-13.81%4.13M
2.10%4.14M
-23.50%3.04M
-21.28%3.44M
-2.19%4.8M
-31.18%4.05M
Long term deferred income
25.36%49.31M
12.77%46.11M
21.03%49.98M
19.51%42.83M
0.51%39.33M
17.61%40.89M
8.04%41.3M
76.73%35.84M
82.50%39.13M
53.79%34.77M
Lease liabilities
4.29%26.04M
62.08%23.81M
50.09%23.97M
104.68%23.6M
122.23%24.96M
27.92%14.69M
19.81%15.97M
-7.53%11.53M
-13.19%11.23M
1.71%11.49M
Total non current liabilities
8.59%433.37M
-12.10%421.38M
-11.63%417.92M
186.58%406.78M
175.85%399.07M
244.71%479.4M
230.39%472.9M
11.33%141.94M
0.01%144.67M
-28.73%139.07M
Total liabilities
-11.60%898.96M
-4.41%966.39M
5.51%1B
67.87%918.58M
154.27%1.02B
189.91%1.01B
177.64%950.67M
71.25%547.2M
5.84%399.95M
-11.18%348.71M
Shareholders equity
Paid-in capital
0.00%201.83M
2.34%201.83M
2.35%201.83M
2.35%201.83M
2.35%201.83M
29.30%197.21M
29.32%197.2M
29.46%197.2M
30.06%197.2M
2.05%152.52M
Other equity instruments
-0.00%69.77M
-21.30%69.77M
-21.30%69.77M
269.98%69.77M
269.99%69.77M
369.69%88.65M
367.54%88.66M
-5.33%18.86M
-20.25%18.86M
-46.51%18.87M
Capital reserve funds
0.00%966.03M
12.81%966.03M
12.82%966.03M
12.84%966.03M
12.84%966.02M
-4.93%856.3M
-4.89%856.25M
-4.35%856.12M
-2.19%856.12M
10.85%900.71M
Surplus reserve funds
8.90%100.93M
8.90%100.93M
8.90%100.93M
19.92%92.68M
19.92%92.68M
19.92%92.68M
19.92%92.68M
15.18%77.29M
15.18%77.29M
15.18%77.29M
Retained profit
21.93%998.33M
19.76%1.05B
19.49%974.77M
26.98%867.9M
28.86%818.78M
30.58%878.38M
32.93%815.77M
33.99%683.52M
32.91%635.4M
31.84%672.69M
Less:Treasury stock
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.12%165.11M
-13.96%165.11M
-14.14%165.11M
Other composite income
40.48%35.96M
30.91%33.76M
14.91%23.06M
34.35%25.45M
-4.24%25.6M
-4.39%25.79M
-9.20%20.07M
-21.85%18.94M
-2.09%26.73M
-18.20%26.97M
Attributable parent company shareholders equity adjustment items
----
----
----
----
----
----
----
----
----
---0.01
Shareholders equity without minority interests
9.86%2.21B
14.45%2.26B
13.95%2.17B
22.04%2.06B
22.05%2.01B
17.22%1.97B
17.65%1.91B
12.17%1.69B
15.05%1.65B
18.98%1.68B
Minority interests
----
----
----
----
----
----
----
-24.53%388.55K
--547.48K
--532.91K
Other items effecting shareholder equity
----
----
----
----
----
----
----
----
----
--0.01
Total shareholder equity
9.86%2.21B
14.45%2.26B
13.95%2.17B
22.01%2.06B
22.01%2.01B
17.18%1.97B
17.62%1.91B
12.15%1.69B
15.08%1.65B
19.02%1.68B
Adjustment items of liabilities and equity
----
----
----
----
----
----
----
----
----
---0.01
Total liabilityies and equity
2.65%3.11B
8.06%3.23B
11.14%3.17B
33.24%2.98B
47.85%3.03B
46.81%2.98B
45.54%2.86B
22.51%2.23B
13.15%2.05B
12.46%2.03B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -35.42%1.1B-0.16%1.62B-1.36%1.5B45.60%1.42B112.04%1.7B130.18%1.62B124.89%1.52B70.23%974.62M14.06%800.04M3.40%705.67M
Transactional financial assets --270M-----------------73.33%30M-76.92%30M-82.35%30M-45.45%30M81.45%112.5M
Notes receivable and accounts receivable 12.60%123.24M29.50%164.35M-18.68%111.93M90.55%119.41M90.60%109.44M43.23%126.92M62.86%137.65M14.08%62.67M34.98%57.42M32.56%88.61M
-Notes receivable 4.33%25.04M-50.50%18.94M-13.10%20.84M--14.28M--24M--38.27M--23.99M------------
-Accounts receivable 14.93%98.2M64.03%145.41M-19.86%91.09M67.76%105.13M48.81%85.44M0.04%88.65M34.48%113.66M14.08%62.67M34.98%57.42M32.56%88.61M
Other receivables (including interest and dividends) -29.94%4.07M28.83%4.6M29.63%3.25M9.87%3.97M64.30%5.81M0.97%3.57M-14.07%2.51M-1.99%3.61M5.79%3.54M24.01%3.54M
-Other receivable -29.94%4.07M----29.63%3.25M----64.30%5.81M-----14.07%2.51M----5.79%3.54M----
Advance payment -27.81%10.4M-20.56%12.07M47.91%20.66M-12.45%12.94M16.91%14.4M40.25%15.19M32.11%13.97M26.09%14.78M23.19%12.32M-23.18%10.83M
Inventories 11.73%207.03M0.93%166.39M6.82%157.83M3.61%179.5M8.29%185.29M26.44%164.85M49.16%147.76M21.42%173.25M15.57%171.11M4.02%130.38M
Receivable financing -9.78%329K346.51%1.38M3,396.58%1.13M-95.13%403.46K-95.89%364.68K-99.00%309.08K-99.90%32.37K-27.08%8.29M-35.12%8.88M40.90%30.99M
Other current assets 318.80%10.75M220.27%12.04M49.88%8.08M-6.34%7.81M-73.57%2.57M22.89%3.76M-28.28%5.39M203.11%8.33M399.59%9.72M61.09%3.06M
Adjustment items of current assets ------0.01--------------------------------
Total current assets -14.55%1.72B0.69%1.98B-2.96%1.81B36.65%1.74B84.28%2.01B81.37%1.97B78.13%1.86B31.54%1.28B11.99%1.09B11.06%1.09B
Non Current assets
Other equity investment 19.50%75.14M14.98%72.56M6.39%59.98M14.67%62.71M-1.49%62.88M-0.35%63.11M-4.26%56.37M-10.95%54.69M-1.81%63.83M-11.63%63.33M
Other non-current financial assets --------------0-----45.65%1.5M-45.65%1.5M-90.06%1.5M-90.06%1.5M-81.71%2.76M
Investment real estate -5.03%218.49M-5.26%220.8M15.12%223.76M15.37%227.08M15.44%230.06M15.51%233.05M-4.81%194.38M-4.76%196.84M-4.06%199.3M-4.00%201.75M
Long-term equity investment 4.76%5.71M-1.54%5.9M-3.20%5.74M-6.93%5.51M-8.78%5.45M-4.59%5.99M23.03%5.93M12.04%5.92M11.54%5.97M12.60%6.28M
Fixed assets -7.77%320.64M-----11.13%335.01M----0.21%347.67M----5.45%376.95M-----3.73%346.94M----
Constru in process 176.79%400.07M----65.19%280.21M-----7.40%144.54M----47.07%169.63M----1,791.18%156.09M----
Productive biological assets -11.95%29.5M-1.98%34.84M4.01%31.38M12.20%30.53M24.27%33.51M37.86%35.55M34.64%30.17M73.70%27.21M32.01%26.96M8.98%25.79M
Intangible assets -5.86%89.26M-8.35%87.76M297.88%310.98M296.38%313.77M17.98%94.81M17.20%95.76M-5.81%78.16M-5.60%79.16M4.33%80.36M4.63%81.7M
Long deferred expense 44.75%70.19M49.85%75.31M50.15%79.78M3.14%45.87M32.72%48.49M37.27%50.26M33.07%53.13M29.29%44.47M1.36%36.54M-2.24%36.61M
Deferred tax assets -----------------------------0.32%311.98K-81.06%278.3K-67.75%366.26K
Usufruct assets 6.91%39.77M42.91%34.46M46.49%35.72M74.10%35.27M95.15%37.2M20.11%24.11M17.77%24.38M16.48%20.26M2.13%19.06M7.94%20.08M
Other non current assets 1,691.46%136.64M804.28%60.65M38.97%4.95M-13.90%12.08M-55.47%7.63M-67.46%6.71M-51.18%3.56M-56.72%14.03M-2.50%17.13M43.89%20.61M
Total non current assets 36.87%1.39B22.34%1.24B37.55%1.37B28.71%1.23B6.11%1.01B7.21%1.02B8.40%994.18M12.25%958.86M14.52%953.96M14.12%947.62M
Total assets 2.65%3.11B8.06%3.23B11.14%3.17B33.24%2.98B47.85%3.03B46.81%2.98B45.54%2.86B22.51%2.23B13.15%2.05B12.46%2.03B
Liabilities
Current liabilities
Short term loan -33.02%246.18M15.18%394.23M36.34%372.16M74.74%332M--367.52M--342.27M--272.97M--190M--------
Notes payable and accounts payable 2.78%167.84M-33.47%97.08M1.29%145.82M-24.72%116.79M-16.08%163.3M-11.61%145.92M2.24%143.96M14.55%155.14M19.81%194.6M28.77%165.1M
-Accounts payable 2.78%167.84M-33.47%97.08M1.29%145.82M-24.72%116.79M-16.08%163.3M-11.61%145.92M2.24%143.96M14.55%155.14M19.81%194.6M28.77%165.1M
Contract liabilities 11.47%9.7M20.18%10.55M8.37%8.98M26.66%10.06M-3.39%8.7M-16.19%8.78M-2.85%8.28M-28.42%7.94M4.09%9.01M5.52%10.47M
Advance receipts 27.93%1.45M-17.11%1.35M50.17%1.13M-66.79%780.61K-32.24%1.13M132.81%1.63M-30.40%751.68K--2.35M--1.67M--701.27K
Salaries payable -8.70%22.42M-4.05%18.42M-9.32%29.09M3.83%29.81M5.02%24.56M7.03%19.2M13.50%32.08M21.10%28.71M23.26%23.38M16.11%17.94M
Taxs payable -2.50%3.4M48.05%6.98M16.01%9.53M7.50%8.67M-60.63%3.49M37.04%4.71M100.04%8.22M-25.21%8.06M155.51%8.86M-40.21%3.44M
Other payable (including interest and dividends) -92.55%2.84M184.51%7.32M-6.35%5.36M-56.13%2.76M231.80%38.1M-55.30%2.57M-42.18%5.73M0.77%6.29M40.59%11.48M15.89%5.76M
-Dividend payable ------------------35.07M--------------------
-Other payable -6.45%2.84M-----6.35%5.36M-----73.59%3.03M-----42.18%5.73M----65.35%11.48M----
Non current liabilities due within one year 5.94%10.68M44.81%7.92M147.88%12.08M66.50%9.81M91.89%10.09M7.99%5.47M-13.48%4.87M59.52%5.89M39.32%5.26M6.56%5.06M
Other current liabilities 9.57%1.07M16.18%1.15M9.90%1M29.13%1.12M-3.91%974.38K-14.92%986.58K-4.96%910K-19.67%865.64K-96.35%1.01M-95.92%1.16M
Total current liabilities -24.65%465.58M2.53%545.01M22.48%585.15M26.29%511.8M142.03%617.86M153.56%531.55M139.75%477.77M111.03%405.26M9.46%255.28M6.17%209.63M
Current liabilities
Bonds payable 6.46%352.01M-17.54%346.05M-17.55%340.19M269.06%336.33M269.41%330.64M372.79%419.67M371.00%412.59M0.83%91.13M-15.06%89.51M-42.86%88.77M
Deferred tax liabilities 45.53%6.02M30.57%5.4M24.10%3.78M16.66%4.01M-13.81%4.13M2.10%4.14M-23.50%3.04M-21.28%3.44M-2.19%4.8M-31.18%4.05M
Long term deferred income 25.36%49.31M12.77%46.11M21.03%49.98M19.51%42.83M0.51%39.33M17.61%40.89M8.04%41.3M76.73%35.84M82.50%39.13M53.79%34.77M
Lease liabilities 4.29%26.04M62.08%23.81M50.09%23.97M104.68%23.6M122.23%24.96M27.92%14.69M19.81%15.97M-7.53%11.53M-13.19%11.23M1.71%11.49M
Total non current liabilities 8.59%433.37M-12.10%421.38M-11.63%417.92M186.58%406.78M175.85%399.07M244.71%479.4M230.39%472.9M11.33%141.94M0.01%144.67M-28.73%139.07M
Total liabilities -11.60%898.96M-4.41%966.39M5.51%1B67.87%918.58M154.27%1.02B189.91%1.01B177.64%950.67M71.25%547.2M5.84%399.95M-11.18%348.71M
Shareholders equity
Paid-in capital 0.00%201.83M2.34%201.83M2.35%201.83M2.35%201.83M2.35%201.83M29.30%197.21M29.32%197.2M29.46%197.2M30.06%197.2M2.05%152.52M
Other equity instruments -0.00%69.77M-21.30%69.77M-21.30%69.77M269.98%69.77M269.99%69.77M369.69%88.65M367.54%88.66M-5.33%18.86M-20.25%18.86M-46.51%18.87M
Capital reserve funds 0.00%966.03M12.81%966.03M12.82%966.03M12.84%966.03M12.84%966.02M-4.93%856.3M-4.89%856.25M-4.35%856.12M-2.19%856.12M10.85%900.71M
Surplus reserve funds 8.90%100.93M8.90%100.93M8.90%100.93M19.92%92.68M19.92%92.68M19.92%92.68M19.92%92.68M15.18%77.29M15.18%77.29M15.18%77.29M
Retained profit 21.93%998.33M19.76%1.05B19.49%974.77M26.98%867.9M28.86%818.78M30.58%878.38M32.93%815.77M33.99%683.52M32.91%635.4M31.84%672.69M
Less:Treasury stock 0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.12%165.11M-13.96%165.11M-14.14%165.11M
Other composite income 40.48%35.96M30.91%33.76M14.91%23.06M34.35%25.45M-4.24%25.6M-4.39%25.79M-9.20%20.07M-21.85%18.94M-2.09%26.73M-18.20%26.97M
Attributable parent company shareholders equity adjustment items ---------------------------------------0.01
Shareholders equity without minority interests 9.86%2.21B14.45%2.26B13.95%2.17B22.04%2.06B22.05%2.01B17.22%1.97B17.65%1.91B12.17%1.69B15.05%1.65B18.98%1.68B
Minority interests -----------------------------24.53%388.55K--547.48K--532.91K
Other items effecting shareholder equity --------------------------------------0.01
Total shareholder equity 9.86%2.21B14.45%2.26B13.95%2.17B22.01%2.06B22.01%2.01B17.18%1.97B17.62%1.91B12.15%1.69B15.08%1.65B19.02%1.68B
Adjustment items of liabilities and equity ---------------------------------------0.01
Total liabilityies and equity 2.65%3.11B8.06%3.23B11.14%3.17B33.24%2.98B47.85%3.03B46.81%2.98B45.54%2.86B22.51%2.23B13.15%2.05B12.46%2.03B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data